
BioLife Solutions BLFS
$ 21.61
1.08%
Quarterly report 2025-Q3
added 11-06-2025
BioLife Solutions ROCE Ratio 2011-2026 | BLFS
Annual ROCE Ratio BioLife Solutions
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.04 | -6.94 | -1.63 | -7.35 | -3.05 | 0.9 | 8.41 | -9.93 | -71.41 | -22.29 | -21.17 | -16.54 | -52.22 | -111.72 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.41 | -111.72 | -22.64 |
Quarterly ROCE Ratio BioLife Solutions
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.29 | -5.4 | -1.01 | -1.52 | -6.18 | -10.72 | -13.33 | -11.48 | -14.38 | -12.61 | -28.29 | -23.27 | -25.55 | -24.93 | -7.24 | -3.76 | -4.36 | -2.69 | -1.66 | -0.41 | -2.18 | -3.35 | -1.65 | 1.24 | 4.01 | 8.56 | 9.82 | 6.07 | 5.75 | 2.66 | -3.7 | -8.3 | -26.77 | -44.91 | -64.89 | -61.88 | -77.12 | -73.89 | -64.11 | -42.46 | -49.87 | -42.04 | -35.98 | -18.06 | -17.23 | -8.99 | -0.84 | 0.0 | 1.2 | 1.56 | 3.39 | 5.08 | 7.63 | 8.99 | 8.86 | 8.94 | 2.55 | 2.33 | 4.06 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 9.82 | -77.12 | -12.87 |
ROCE Ratio of other stocks in the Medical instruments industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
9.3 | - | - | $ 810 M | ||
|
iRhythm Technologies
IRTC
|
-37.58 | $ 127.33 | 4.07 % | $ 4.08 B | ||
|
Repro Med Systems
KRMD
|
-17.44 | $ 4.05 | 2.15 % | $ 187 M | ||
|
Microbot Medical
MBOT
|
-19.01 | $ 2.17 | -1.14 % | $ 99.4 M | ||
|
Milestone Scientific
MLSS
|
-202.54 | $ 0.32 | 0.62 % | $ 26.3 M | ||
|
Luminex Corporation
LMNX
|
5.75 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
-131.33 | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
-2.56 | $ 76.22 | 0.57 % | $ 40.4 B | ||
|
Ekso Bionics Holdings
EKSO
|
-147.62 | $ 10.91 | -2.42 % | $ 26.5 M | ||
|
STERIS plc
STE
|
13.12 | $ 222.6 | 0.38 % | $ 21.9 B | ||
|
The Cooper Companies
COO
|
8.29 | $ 64.72 | 0.47 % | $ 12.9 B | ||
|
Teleflex Incorporated
TFX
|
0.44 | $ 136.19 | -0.27 % | $ 6.08 B | ||
|
Antares Pharma, Inc.
ATRS
|
9.12 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
2.55 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
-3.75 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
11.0 | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
17.41 | - | -0.02 % | $ 16.3 B | ||
|
Haemonetics Corporation
HAE
|
27.02 | $ 61.38 | 2.42 % | $ 3.09 B | ||
|
electroCore
ECOR
|
769.63 | $ 6.1 | -1.3 % | $ 51.7 K | ||
|
ICU Medical
ICUI
|
2.02 | $ 123.48 | -1.07 % | $ 3.04 B | ||
|
Envista Holdings Corporation
NVST
|
6.96 | $ 26.81 | 0.07 % | $ 4.5 B | ||
|
Isoray
ISR
|
-54.85 | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
16.53 | $ 476.5 | -1.19 % | $ 170 B | ||
|
West Pharmaceutical Services
WST
|
18.42 | $ 302.8 | -1.01 % | $ 21.9 B | ||
|
Glaukos Corporation
GKOS
|
-27.87 | $ 122.15 | 0.4 % | $ 5.92 B | ||
|
Masimo Corporation
MASI
|
-25.35 | $ 178.64 | - | $ 9.52 B | ||
|
InfuSystem Holdings
INFU
|
3.45 | $ 10.87 | 5.13 % | $ 224 M | ||
|
Merit Medical Systems
MMSI
|
11.66 | $ 67.66 | -1.35 % | $ 4 B | ||
|
Utah Medical Products
UTMD
|
9.56 | $ 67.0 | -0.25 % | $ 217 M | ||
|
Pulse Biosciences
PLSE
|
-95.39 | $ 22.9 | -0.52 % | $ 1.54 B | ||
|
DENTSPLY SIRONA
XRAY
|
-31.52 | $ 11.92 | 0.04 % | $ 2.38 B | ||
|
Retractable Technologies
RVP
|
-28.47 | $ 0.64 | -2.14 % | $ 19.2 M | ||
|
Pro-Dex
PDEX
|
22.96 | $ 51.58 | -1.0 % | $ 170 M | ||
|
LeMaitre Vascular
LMAT
|
17.26 | $ 115.44 | 1.75 % | $ 2.61 B | ||
|
Predictive Oncology
POAI
|
-379.14 | - | - | $ 31.1 M | ||
|
STAAR Surgical Company
STAA
|
-26.65 | $ 26.36 | 2.69 % | $ 1.31 B | ||
|
Stereotaxis
STXS
|
-164.02 | $ 1.95 | 0.78 % | $ 177 M | ||
|
Baxter International
BAX
|
-5.03 | $ 18.23 | 0.39 % | $ 9.35 B | ||
|
ResMed
RMD
|
22.7 | $ 221.41 | 0.71 % | $ 32.3 B | ||
|
AtriCure
ATRC
|
-1.92 | $ 29.44 | 0.55 % | $ 1.41 B | ||
|
Harvard Bioscience
HBIO
|
-353.72 | $ 6.59 | -4.01 % | $ 293 M | ||
|
NeuroMetrix
NURO
|
-61.36 | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
-21.84 | $ 11.15 | 0.45 % | $ 456 M | ||
|
Becton, Dickinson and Company
BDX
|
10.16 | $ 151.43 | -0.45 % | $ 43.6 B | ||
|
Nephros
NEPH
|
-19.06 | $ 2.98 | 3.83 % | $ 31 M | ||
|
OraSure Technologies
OSUR
|
-19.81 | $ 2.96 | -1.33 % | $ 218 M | ||
|
Repligen Corporation
RGEN
|
1.79 | $ 118.29 | 0.59 % | $ 6.59 M |